Experiment 68816

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismHypericum perforatum (CLUSIACEAE)
CitationHOLSBOER-TRACHSLER,E: VANONI,CH:. (1999). CLINICAL EFFICACY AND TOLERANCE OF THE HYPERICUM SPECIAL EXTRACT LI 160 IN DEPRESSIVE DISORDERS - A DRUG MONITORING STUDY.. 88(37)
Amount utilized
Compound isolated
Disease647 PATIENTS SUFFERING FROM MILD TO MODERATE DEPRESSION TREATED FOR 6 WEEKS WITH HYPERICUM EXTRACT LI 160 (JARSIN 300), 1 TABLET T.I.D. THE CONDITION OF THE PATIENTS IMPROVED IN 75% (PRIMARY ENDPOINT). THE VON ZERSSEN DEPRESSION SCORE DECREASED FROM 19.8-21.2 (95%-CI) AT BASELINE TO 8.1-9.3 AT WEEK 6 (P<0.001). ALL SYMPTOMS WERE IMPROVED AT WEEK 3 AND FURTHER AT WEEK 6. THE CONDITION IMPROVED SOMEWHAT SLOWER IN PATIENTS OLDER THAN 65 YEARS. THE SEVERITY OF THE DEPRESSION DID NOT APPEAR TO HAVE AN EFFECT ON THE OUTCOME. ADVERSE EVENTS WERE REPORTED BY 17% OF THE PATIENTS (GASTROINTESTINAL 10%). THESE WERE MOSTLY MILD OR MODERATE. TOLERANCE WAS RATED IN 89% AS SATISFACTORY OR BETTER. A COMMERCIAL PRODUCT, LI-160, WAS USED.
Dose amount900.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT
GenderGIVEN TO BOTH SEXES